Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment

Summary

Actinic cheilitis is a major potentially carcinogenic disorder of the lower lip and several reports of clinical cases with excellent results for the treatment of this lesion that can differentiate to squamous cell carcinoma of the lip. However, clinical trials are lacking to define the optimal dosage of the drug for a therapeutic modality and to define its true efficacy in controlled studies of this pre-malignant labial lesion.

Timeline

Start

2020-02

Primary completion

2021-09

Completion

2022-04

Drugs

Indications